18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor

被引：22
作者：
Acar, Emine [1 ]
Kaya, Gamze Capa [2 ]
机构：
[1] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Nucl Med, Izmir, Turkey
[2] Dokuz Eylul Univ, Sch Med, Dept Nucl Med, Izmir, Turkey
来源：
CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 01期
关键词：
DOTATATE; FDG; large cell neuroendocrine prostate cancer; PET/CT; PSMA; GA-68-PSMA; DIFFERENTIATION; CARCINOMA; UTILITY; CANCER; PET/CT;
D O I：
10.1097/RLU.0000000000002322
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Prostate large cell neuroendocrine tumor is a rare disease. In this case, metastatic areas showing FDG uptake, somatostatin receptor positivity, and PSMA expression are shown in F-18-FDG PET/CT, Ga-68-DOTATATE PET/CT, and Ga-68-PSMA PET/CT in a 70-year-old man with the diagnosis of prostate large cell neuroendocrine carcinoma.
引用
收藏
页码：53 / 54
页数：2
相关论文
共 8 条
[1]   Metastatic Poorly Differentiated Prostatic Carcinoma With Neuroendocrine Differentiation Negative on 68Ga-PSMA PET/CT [J].
Chakraborty, Partha Sarathi ;
Tripathi, Madhavi ;
Agarwal, Krishan Kant ;
Kumar, Rajeev ;
Vijay, Maneesh Kumar ;
Bal, Chandrasekhar .
CLINICAL NUCLEAR MEDICINE, 2015, 40 (02) :E163-E166
[2]   68Ga-DOTATOC and 68Ga-PSMA PET/CT Unmasked a Case of Prostate Cancer With Neuroendocrine Differentiation [J].
Chen, Sirong ;
Cheung, Shing Kee ;
Wong, Ka-nin ;
Wong, Kwok Kee ;
Ho, Chi-lai .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) :959-960
[3]   FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate [J].
Liu, Yiyan .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2008, 6 (1)
[4]  
Okoye E, 2014, INT J CLIN EXP PATHO, V7, P9061
[5]   Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT [J].
Parida, Girish Kumar ;
Tripathy, Sarthak ;
Gupta, Shreya Datta ;
Singhal, Abhinav ;
Kumar, Rakesh ;
Bal, Chandrasekhar ;
Shamim, Shamim Ahmed .
CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) :248-249
[6]   Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification [J].
Priemer, David S. ;
Montironi, Rodolfo ;
Wang, Lisha ;
Williamson, Sean R. ;
Lopez-Beltran, Antonio ;
Cheng, Liang .
ENDOCRINE PATHOLOGY, 2016, 27 (02) :123-135
[7]   Utility of FDG-PET in clinical neuroendocrine prostate cancer [J].
Spratt, Daniel E. ;
Gavane, Somali ;
Tarlinton, Lisa ;
Fareedy, Shoaib B. ;
Doran, Michael G. ;
Zelefsky, Michael J. ;
Osborne, Joseph R. .
PROSTATE, 2014, 74 (11) :1153-1159
[8]   Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT [J].
Usmani, Sharjeel ;
Ahmed, Najeeb ;
Marafi, Fahad ;
Rasheed, Rashid ;
Amanguno, Henney G. ;
al Kandari, Fareeda .
CLINICAL NUCLEAR MEDICINE, 2017, 42 (05) :410-413
1